Title of article :
Orbital mucormycosis in an immunocompetent individual
Author/Authors :
Badiee, P Alborzi Clinical Microbiology Research Center , Jafarpour, Z Alborzi Clinical Microbiology Research Center , Alborzi, A Alborzi Clinical Microbiology Research Center , Haddadi, P Shiraz University of Medical Sciences, Shiraz , Rasuli, M Alborzi Clinical Microbiology Research Center , Kalani, M Alborzi Clinical Microbiology Research Center
Abstract :
Background: Orbital mucormycosis caused by Zygomycetes is a rare and fatal infection that generally affects the patients
who are immunocompromised. Despite antifungal therapy and aggressive surgical intervention, mucormycosis can
cause serious and rapidly fatal infections if delayed diagnosis or therapeutic management occurs. Here, we report orbital
mucormycosis in a healthy boy, with a favorable outcome after aggressive treatment. He has had no recurrence since the end
of his treatment.
Case present: A 2-year old healthy boy, some days after entry of dust particle to his left eye presented with swelling
and redness of the eye. With diagnosis of “periorbital cellulitis” intravenous antibiotics vancomycin (40 mg/kg/day) and
ceftriaxone (75 mg/kg/day) were started but no improvement was observed. The results of biopsy and tissue culture led us
to a diagnosis of mucormycosis. Orbital exenteration, combined with intravenous amphotericin B (1 mg/kg/day), resulted in
the patient’s survival.
Conclusion: Due to the high mortality rate of mucormycosis, early diagnosis based on clinical findings and biopsy could be
effective for management of the patients suffering from this infection.
Keywords :
mucormycosis , immunocompetent , orbital exentration , amphotericin B
Journal title :
Astroparticle Physics